SPACInsider Logo
Replay Acquisition Corp. Pricing Their $250 Million SPAC Tonight
by Kristi Marvin on 2019-04-03 at 1:37pm

Replay Acquisition Corp. (RPLA.U), is getting set to price their $250 million Brazil/Argentina-focused SPAC tonight, with an 8-a12b filing along with their CERT.  Replay will be the first SPAC out of the gate for Q2, but both B. Riley Principal Merger and Iswill will follow hot on their heels next week.

This will be the second effort in 2019 from the SPAC underwriting team of Credit Suisse and BofA Merrill Lynch, which most recently underwrote Crescent Acquisition Corp.  When two underwriters work well together, why mess with success? That seems to be the case for Cowen/Chardan and Cantor/BTIG as well.

Stay tuned for any surprise up-sizes or changes to terms.

Summary of terms below:

Replay terms

Credit Suisse and BofA Merrill Lynch are joint-running managers, I-Bankers Securities, Inc. is co-manager.
Greenberg Traurig, LLP and Kirkland & Ellis LLP, are Issuer’s Counsel and Underwriter’s Counsel, respectively.


Recent Posts
by Marlena Haddad on 2022-12-01 at 11:25am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...

by Marlena Haddad on 2022-12-01 at 10:02am

InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...

by Nicholas Alan Clayton on 2022-12-01 at 9:31am

Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...

by Marlena Haddad on 2022-12-01 at 9:22am

Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...

by Nicholas Alan Clayton on 2022-11-30 at 6:01pm

The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved